title: Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.
abstract: The BCR/ABL fusion protein is a constitutively active tyrosine kinase that is responsible for the pathogenesis of chronic myelogenous leukemia (CML). Clinically, CML is characterized by a chronic phase (CP) that eventually terminates into a blast crisis (BC). BC transformation is associated with accumulation of CD34+ blasts. We investigated the expression and phosphorylation of Src-homology-2 and collagen-homology domains (SHC) [corrected] proteins in subpopulations of CML primary cells. Shc polypeptides are tyrosine kinase substrates that are constitutively tyrosine-phosphorylated in continuous cell lines of CML origin. High levels of Shc expression were found in the CD34+ cells from CML-BC, CML-CP and normal bone marrow. In contrast, CD34- fractions from CML-CP and normal bone marrow expressed low levels of p46Shc. Shc proteins were constitutively phosphorylated in the CD34+ fractions from CML cells (both CP and BC), but not in normal CD34+ cells. These data bear implications for the role of Shc in normal hemopoiesis and CML leukemogenesis: (a) dramatic changes of Shc expression during terminal differentiation of hemopoietic cells adds a further level of regulation to the signal transduction function of Shc; and (b) constitutive Shc tyrosine-phosphorylation in the rare CD34+ cells of CML-CP might contribute to the selection of this subpopulation during the blast crisis transformation of CMLs.
authors.affiliation: The Institute of Medical Pathology, University of Parma, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Bonati
authors.forename: C
authors.initials: C
authors.lastname: Carlo-Stella
authors.forename: P
authors.initials: P
authors.lastname: Lunghi
authors.forename: R
authors.initials: R
authors.lastname: Albertini
authors.forename: S
authors.initials: S
authors.lastname: Pinelli
authors.forename: E
authors.initials: E
authors.lastname: Migliaccio
authors.forename: G
authors.initials: G
authors.lastname: Sammarelli
authors.forename: B
authors.initials: B
authors.lastname: Savoldo
authors.forename: A
authors.initials: A
authors.lastname: Tabilio
authors.forename: P P
authors.initials: PP
authors.lastname: Dall'Aglio
authors.forename: P G
authors.initials: PG
authors.lastname: Pelicci
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D033942:Adaptor Proteins, Vesicular Transport; D018952:Antigens, CD34 / Q000032:analysis*; D001853:Bone Marrow / Q000737:chemistry; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism*; D010766:Phosphorylation; D011506:Proteins / Q000032:analysis / Q000378:metabolism*; D055765:Shc Signaling Adaptor Proteins; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; D018909:src Homology Domains
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D033942:Adaptor Proteins, Vesicular Transport; D018952:Antigens, CD34; D011506:Proteins; C528024:SHC1 protein, human; D055765:Shc Signaling Adaptor Proteins; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; D016179:Granulocyte Colony-Stimulating Factor